Basics ImmunityBio, Inc. Common Stock IPO Date: July 27, 2015 Sector: Healthcare Industry: Biotech Market Cap: $2.27B Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 4.51% Avg Daily Range (30 D): $0.06 | 2.28% Avg Daily Range (90 D): $0.08 | 2.80% Institutional Daily Volume Avg Daily Volume: 3.45M Avg Daily Volume (30 D): 8.14M Avg Daily Volume (90 D): 8.4M Trade Size Avg Trade Size (Sh.): 211 Avg Trade Size (Sh.) (30 D): 415 Avg Trade Size (Sh.) (90 D): 400 Institutional Trades Total Inst.Trades: 1,174 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $1.24M Avg Inst. Trade (90 D): $1.48M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.9M Avg Closing Trade (30 D): $.87M Avg Closing Trade (90 D): $1.15M Avg Closing Volume: 351.5K     News Aug 28, 2025 @ 2:44 PM FDA Tightens Survival Standards as Cancer Drug Pip... Source: Prnewswire Jul 9, 2025 @ 12:30 PM Breaking Through: Systemic Genetic Medicines for H... Source: Prnewswire Aug 23, 2024 @ 8:30 PM HCW Biologics Reports Second Quarter 2024 Financia... Source: N/A Jun 26, 2024 @ 1:41 PM ImmunityBio (IBRX) Gains 17% in the Past Week: Her... Source: Zacks Equity Research Mar 20, 2024 @ 3:41 PM Sportradar Group Posts Upbeat Earnings, Joins King... Source: Avi Kapoor Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.1 $-.15 $-.12 Diluted EPS $-.1 $-.15 $-.14 Revenue $ 26.43M $ 16.52M $ 6.11M Gross Profit $ 26.29M $ 16.46M $ Net Income / Loss $ -92.57M $ -129.67M $ -85.75M Operating Income / Loss $ -71.29M $ -64.43M $ -80.25M Cost of Revenue $ .14M $ .06M $ M Net Cash Flow $ 76.92M $ -82.76M $ -18.15M PE Ratio